Journal profile · Medicine-Histology
Matrix Biology Plus
ISSN 2590-0285 · Elsevier · Netherlands
Matrix Biology Plus: impact factor 5.9 (journal website); fully open access; APC about USD 2,890; median 104 days to acceptance (29 articles, last 24 months); 19 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Matrix Biology Plus is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Cell Adhesion Molecules Research, Connective tissue disorders research and Proteoglycans and glycosaminoglycans research, together about 30.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Matrix Biology Plus, a companion title to Matrix Biology, is an online-only, open access, peer-reviewed journal. It offers the quality, visibility, and impact of Matrix Biology, combined with the convenience and reach of timely on-line access for the readers in the matrix biology community.Matrix Biology Plus has a broader scope than Matrix Biology, including computational biology, biomaterials, biophysics, and bioengineering research in addition to or in combination with biology and medicine.Matrix Biology Plus welcomes:Comparative and correlative studies focused on extracellular matrix and cell-matrix interactionsNew methodologies for studying extracellular matrix and cell-matrix interactions in health and diseaseNew structural/biochemical and biophysical, biological or bioengineering models and tools (e.g., detailed description of novel transgenic mice, novel disease models, novel biomaterials, novel bioengineering devices and strategies focused on the matrix)New computational tools for matrix modeling and newly established databases and repositories focused on the matrix and its componentsOmics datasets that are novel, experimentally derived, descriptive, and comprehensive (e.g., proteomics, transcriptomics, genomics, metabolomics, and interactomics datasets). However, simple analysis of published datasets or extraction from public-access databases where no further substantive experimental or computational analysis is undertaken is unlikely to be deemed appropriate.Genomics/transcriptomic studiesMatrix-targeted therapeutics (chemistry, engineering, fabrication/manufacture, target validation, drug delivery, nanomedicine) and matrix-derived therapeuticsClinical and population-based studies of matrix components and disease linked mutationsTo be considered for publication, submitted articles must report novel findings that provide a substantive advance in the field of matrix biology without a strict requirement for novel biological mechanisms. High-quality, descriptive analyses are encouraged.Reasons to submit your next article to Matrix Biology Plus:Publish articles across disciplinary boundaries, including engineering, material and computer/data sciences, epidemiology, and geneticsAdditional figures and tables can be uploadedYoung journal with a commitment for growthAccessibility - Open access provides immediate and free online access to articles by anyone, anywhere in the world. No subscription needed.Speed - Articles are published online, quickly after acceptance. Articles are published constantly so there are no print delays or long waits for the next issue to be published.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Histology
Editor-in-chief Sylvie Ricard-BlumPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 53, United Kingdom 18, Germany 10, Japan 9, Canada 7 (122 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cell Adhesion Molecules ResearchMedicine12.2%
- Connective tissue disorders researchBiochemistry, Genetics and Molecular Biology9.6%
- Proteoglycans and glycosaminoglycans researchBiochemistry, Genetics and Molecular Biology8.5%
- Protease and Inhibitor MechanismsBiochemistry, Genetics and Molecular Biology7.4%
- Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology6.7%
- Tendon Structure and TreatmentMedicine6.3%
- Tissue Engineering and Regenerative MedicineMedicine5.2%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 5.9Publisher website ·
- CiteScore 2026-06
- 7.3LetPub ·
- CiteScore (publisher)
- 7.3Publisher website ·
- SJR 2026-06
- 1.16LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 35OpenAlex ·
- i10-index
- 110OpenAlex ·
- 2-year mean citedness
- 3.51OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 182 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 16 | 16 | 3 |
| 2025 | 19 | 19 | 26 |
| 2024 | 24 | 24 | 178 |
| 2023 | 12 | 12 | 151 |
| 2022 | 26 | 26 | 525 |
| 2021 | 38 | 38 | 1,134 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
104 daysMedian, submission to acceptance · P25–P75 76 days – 139 days
- Acceptance to online
- median 3 days (29 articles)
- Submission to online
- median 108 days
- Sample
- 29 articles with submission and acceptance dates (41 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 35 daysPublisher website ·
- Submission to acceptance
- 130 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,890 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,360 / EUR 2,210 / GBP 1,890 / JPY 292,710 | — | — | |
| LetPub | USD 1,870 | Yes | — | |
| Publisher website | USD 3,400 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
Article types accepted9, with length limits
- brief reportare short papers that meet the same standards of quality and field of interest as regular papers, but have a narrower scope and a more focused interest. Brief r…figures and tables ≤ 3
- brief reportsBrief Reports are short papers that meet the same standards of quality and field of interest as regular papers, but have a narrower scope and a more focused int…Length not stated
- commentariesCommentaries are brief reviews that present a sharply focused view of a rapidly advancing area of research.Length not stated
- commentaryare brief reviews that present a sharply focused view of a rapidly advancing area of research. Authorship is normally by invitation. Generally, commentaries inc…Length not stated
- full length reviewsFull Length Reviews are comprehensive and critical analyses of topics that have been under investigation for some time.Length not stated
- mini revieware timely and original analyses of current topics of high interest. The mini-reviews should summarize the general concepts in the field, provide a brief summar…Length not stated
- mini reviewsMini Reviews are timely and original analyses of current topics of high interest.Length not stated
- protocols and methodsMatrix Biology Plus welcomes submissions that advance methods, experimental protocols, or computational approaches for investigating the extracellular matrix.Length not stated
- regular research papersRegular Research Papers are studies utilizing most scientific technologies including molecular biology, cell biology, immunochemistry, structural biology, compu…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Elsevier Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2590-0285
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Matrix Biology Plus
What is the impact factor of Matrix Biology Plus?
The journal's website gives an impact factor of 5.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 7.3, h-index 35.
How long does peer review take at Matrix Biology Plus?
Based on the dates recorded on 29 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 76–139 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Matrix Biology Plus?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Matrix Biology Plus based?
Of the 122 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (53), United Kingdom (18) and Germany (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Matrix Biology Plus?
According to LetPub and DOAJ records, Matrix Biology Plus is indexed in Scopus and DOAJ.
Is Matrix Biology Plus open access, and what is the APC?
Matrix Biology Plus is a fully open-access journal. APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .